People, Pipelines, and Projections: Helping Emerging Therapeutics Get to Market Efficiently
From tools and assays, to the need for improved collaboration, the potential answers to this question are numerous. IPT asked representatives from DeciBio, Cybin, and GORE PharmBIO for their opinions